Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

NCT05289830 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Pancreatic Ductal Adenocarcinoma
Periampullary Cancer

Interventions

DRUG: Escitalopram
OTHER: Placebo

Sponsor

Case Comprehensive Cancer Center